| Company Name: |
Pharmalego |
| Tel: |
18321033991 |
| Email: |
marketing@pharmalego.com |
|
| | 1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxy-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione Basic information |
| Product Name: | 1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxy-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | | Synonyms: | 1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxy-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione;1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxy-3-methyltetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione;Uridine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-2′-fluoro-2′-methyl-, (2′R)-;3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-4-fluoro-5-[6-(methylamino)purin-9-yl]tetrahydrofuran-3-yl]oxy(diisopropylamino)phosphanyl]oxypropanenitrile | | CAS: | 1244762-79-5 | | MF: | C31H31FN2O7 | | MW: | 562.59 | | EINECS: | | | Product Categories: | | | Mol File: | 1244762-79-5.mol |  |
| | 1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxy-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione Chemical Properties |
| density | 1.367±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 9.370±0.10(predicted) |
| | 1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxy-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione Usage And Synthesis |
| | 1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxy-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione Preparation Products And Raw materials |
|